文献速递青光眼小儿眼科与斜弱视

SVEP1作为TEK相关原发性先天性青光眼的遗传修饰因子

SVEP1 as a Genetic Modifier of TEK-Related Primary Congenital Glaucoma.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2020-01-01

研究纳入了8个TEK相关原发性先天性青光眼(PCG)家系,通过外显子测序、细胞功能实验、小鼠组织染色及人眼组织学检查,发现TEK单倍剂量不足可致PCG,其中两个家系证实常染色体显性遗传;家系8中SVEP1:p.R997C突变与更高的疾病外显率和严重程度相关,SVEP1可能通过影响Schlemm管发育中TEK的表达来修饰疾病表型。

要点

  • TEK单倍剂量不足可解释不同人群中5%的PCG,外显率低与Schlemm管发育异常程度可变有关。
  • 两个家系观察到亲子代疾病传递,支持TEK相关PCG的常染色体显性遗传模式。
  • SVEP1:p.R997C可能作为修饰因子影响TEK表达,增加PCG外显率和严重程度。

核心结论

  • TEK单倍剂量不足可导致PCG,两个家系证实常染色体显性遗传。
  • SVEP1:p.R997C可能作为TEK表达的修饰因子,影响Schlemm管发育,从而改变PCG的外显率和严重程度。

研究设计与样本

  • 研究纳入8个TEK相关PCG家系,通过外显子测序鉴定等位基因频率小于0.0001(gnomAD)的编码/剪接位点变异。
  • 在转染构建体的HEK293细胞中检测自磷酸化(活性)TEK蛋白以评估TEK变异效应。
  • 对家系8一名受累成员的眼球进行组织学检查。
  • 通过免疫荧光染色检测7天小鼠前节发育中流出组织的SVEP1表达。
  • 用人脐静脉血管内皮细胞(HUVEC)经TaqMan定量PCR测量SVEP1对TEK表达的刺激作用。

主要发现

  • 在8个PCG家系中鉴定出杂合TEK功能丧失等位基因,其中两个家系观察到亲子代疾病传递。
  • 家系8表现出更高的疾病外显率和严重程度,组织学显示一只眼缺乏Schlemm管。
  • 家系8的5名受累个体中有4名携带SVEP1:p.R997C。
  • 在Schlemm管发育过程中,SVEP1由周围组织分泌。
  • SVEP1:p.R997C削弱了HUVEC中SVEP1对TEK表达的刺激作用。

临床怎么用

  • 对TEK相关PCG家系可考虑评估SVEP1等修饰基因,以辅助判断疾病外显率和严重程度。
  • TEK单倍剂量不足导致的PCG表现为常染色体显性遗传,家系成员应关注遗传咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Affecting children by age 3, primary congenital glaucoma (PCG) can cause debilitating vision loss by the developmental impairment of aqueous drainage resulting in high intraocular pressure (IOP), globe enlargement, and optic neuropathy. TEK haploinsufficiency accounts for 5% of PCG in diverse populations, with low penetrance explained by variable dysgenesis of Schlemm's canal (SC) in mice. We report eight families with TEK-related PCG, and provide evidence for SVEP1 as a disease modifier in family 8 with a higher penetrance and severity. METHODS: Exome sequencing identified coding/splice site variants with an allele frequency less than 0.0001 (gnomAD). TEK variant effects were assayed in construct-transfected HEK293 cells via detection of autophosphorylated (active) TEK protein. An enucleated eye from an affected member of family 8 was examined via histology. SVEP1 expression in developing outflow tissues was detected by immunofluorescent staining of 7-day mouse anterior segments. SVEP1 stimulation of TEK expression in human umbilical vascular endothelial cells (HUVECs) was measured by TaqMan quantitative PCR. RESULTS: Heterozygous TEK loss-of-function alleles were identified in eight PCG families, with parent-child disease transmission observed in two pedigrees. Family 8 exhibited greater disease penetrance and severity, histology revealed absence of SC in one eye, and SVEP1:p.R997C was identified in four of the five affected individuals. During SC development, SVEP1 is secreted by surrounding tissues. SVEP1:p.R997C abrogates stimulation of TEK expression by HUVECs. CONCLUSIONS: We provide further evidence for PCG caused by TEK haploinsufficiency, affirm autosomal dominant inheritance in two pedigrees, and propose SVEP1 as a modifier of TEK expression during SC development, affecting disease penetrance and severity.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Young TL, Whisenhunt KN, Jin J, et al. SVEP1 as a Genetic Modifier of TEK-Related Primary Congenital Glaucoma. Invest Ophthalmol Vis Sci. 2020. PMID: 33027505. doi:10.1167/iovs.61.12.6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。